Exchange: OTC·Updated 10:06 AM EDT

ADYX Adynxx Inc

$0.0001
$0.00
(0.00%)
Today
Mkt Cap$581.00
Vol353.00

About ADYX

Adynxx, Inc. is a clinical stage biopharmaceutical company, which engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in 2007 and is headquartered in San Francisco, CA.
49

Neutral Sentiment

How do you feel about ADYX?

Advertisement|Remove ads.